USPTO serial 79279289
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
CN
Other trademarks owned by ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
CN
Other trademarks owned by ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
CN
Other trademarks owned by ADLITE MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Weibo Zhang
Suite 717, 136-68 Roosevelt AveFlushing, NY 11354UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 010 | (LED) apparatus for lighting, incorporated into medical instruments; ophthalmoscopes; mirrors for dentists; ultraviolet lamps for medical purposes; medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 15, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 18, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 18, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 15, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 15, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 29, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 29, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 9, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 25, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 17, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 17, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 1, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 29, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |